Tag:

Paxlovid

COVID-19: Biden Tests Positive, Has 'Mild Symptoms' COVID-19: Biden Tests Positive, Has 'Mild Symptoms'
Covid-19: Biden Tests Positive, Has 'Mild Symptoms' President Joe Biden has tested positive for COVID-19, the White House announced on Thursday morning, July 21. The 79-year-old Biden, who is fully vaccinated and double boosted, is "experiencing very mild symptoms," the White House says. Biden tested posted after a trip to Somerset, Massachusetts on Wednesday, July 20. Biden has begun taking the therapeutic Paxlovid, the White House said. "Consistent with CDC guidelines, he will isolate at the White House and will continue to carry out all of his duties fully during that time," the White House said. "He has been in contact with members of …
COVID-19: FDA OKs First Authorized Home Treatment For Virus COVID-19: FDA OKs First Authorized Home Treatment For Virus
Covid-19: FDA OKs First Authorized Home Treatment For Virus The fight against COVID-19 took a step forward as federal health officials authorized the first pill that Americans will be able to take at home to head off the worst effects of the virus. On Wednesday, Dec. 22, the US Food and Drug Administration (FDA) granted emergency authorization for Pfizer’s COVID-19 treatment pill, which has been recommended for people at high risk of developing severe cases of COVID-19. The pill could be available as soon as this weekend, according to Pfizer CEO Albert Bourla. Related story - COVID-19: Pfizer Releases Data On Anti-Viral Pill's Effective…
COVID-19: Pfizer Releases Data On Anti-Viral Pill's Effectiveness Vs. Omicron, Severe Disease COVID-19: Pfizer Releases Data On Anti-Viral Pill's Effectiveness Vs. Omicron, Severe Disease
Covid-19: Pfizer Releases Data On Anti-Viral Pill's Effectiveness Vs. Omicron, Severe Disease Brand-new laboratory studies are shedding light on the effectiveness of Pfizer's anti-viral COVID-19 pill both against the Omicron variant and in warding off severe disease. The studies showed the pill, called Paxlovid, reduced the risk of hospitalization or death by nearly 90 percent if given to high-risk adults within several days of their initial COVID symptoms, Pfizer said in a statement released Tuesday morning, Dec. 14. The pill also retains activity against variants, including Omicron, because the drug blocks an enzyme involved in viral replication, Pfizer said. “Emerging …